The cheapest alternative to Wegovy is Wegovy's own molecule, semaglutide, compounded by a licensed pharmacy and sold through a telehealth program. It costs a fraction of Novo Nordisk's price and it is not FDA-approved. Everything else on this page is an approved drug, and each one is cheaper than a pharmacy-priced Wegovy pen in a different way: a cheaper way to buy Wegovy itself, a pill, a different molecule, or a diabetes label your insurance may already pay for. Here is the floor today, read from every partner program we track:
Below, each alternative in the order most people look at them, with what it costs to stay on it, not just the first month.
Semaglutide, compounded
Compounded semaglutide is the alternative most people who search this end up choosing, because it uses semaglutide as its active ingredient at a much lower monthly price. The trade is the approval. In FDA's words: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."1 The pharmacy's state licence, not an FDA review of the finished product, is what stands behind the vial.
Every price below is read from the seller's own page, ranked cheapest first, with any membership fee counted in:
Before you pick one, read how compounded semaglutide compares with Wegovy and check the seller in ten minutes. A price gap this large attracts bad actors as well as good pharmacies.
First, the cheaper Wegovy
If the problem is the pharmacy price, the next alternative is Wegovy bought another way. Novo Nordisk sells it directly to people paying cash through NovoCare Pharmacy. New self-pay patients pay $199 for each of the first two months at 0.25 mg and 0.5 mg, then $349 a month for every pen dose up to 2.4 mg, and $399 for the 7.2 mg high dose.2 The two-month starter offer runs "through December 31, 2026", in Novo's words.
That is still $349 a month at the doses that do the work. The Wegovy cost guide prices the whole first year.
No needles: the Wegovy pill and Foundayo
Two weight-loss pills are now approved, and both are priced below the Wegovy pen at their starting doses.
The Wegovy pill is oral semaglutide, the same molecule as the pen. In Novo Nordisk's own words, "Wegovy is the first FDA-approved semaglutide pill for weight loss."3 NovoCare sells it to self-pay patients at $149 for each month of 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg.2 At every dose that is less than the $349 pen.
Foundayo is orforglipron, Lilly's pill. Lilly says "Individuals opting for self-pay can access Foundayo starting at $149 per month for the lowest dose." In the ATTAIN-1 trial, people on the highest dose who stayed on treatment lost 12.4% of their body weight, against 0.9% on placebo.7 That is a smaller average loss than the injections, in a different trial, so treat the comparison as rough.
Programs on our board that sell an oral GLP-1, cheapest first:
More in the Wegovy pill vs injection guide and the Foundayo vs Wegovy pill guide.
A stronger molecule: tirzepatide
Zepbound is Lilly's tirzepatide, approved for weight loss, and it is the approved alternative people compare Wegovy with most. The two drugs were tested against each other in SURMOUNT-5, a 72-week trial of 751 adults with obesity: tirzepatide reduced weight by 20.2% and semaglutide by 13.7%.4 If Wegovy is not working well enough, this is the alternative with the trial behind it.
Lilly sells Zepbound to people paying cash, priced by dose. Its self-pay ladder, from the manufacturer prices we track, is below; the Zepbound cost without insurance guide works through the first year.
Tirzepatide is also sold compounded, by many of the same programs. The same FDA caveat applies.1
The Zepbound vs Wegovy guide goes through the two side by side, and the switching guide quotes what the labels say about moving from one to the other.
Ozempic alternatives
Ozempic is semaglutide too, made by Novo Nordisk. Its label reads "OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus."8 So the answer to "what is an alternative to Ozempic" depends on why you take it.
If you want it for weight loss
Everything above this heading applies to you, because Wegovy is the weight-loss label of the same molecule. Plans that refuse Wegovy generally will not pay for Ozempic off label either, and whether to prescribe it is your clinician's call. Paying cash, Ozempic is not cheaper than Wegovy: NovoCare charges new self-pay patients $199 for each of the first two months, then $349 a month up to 1 mg and $499 for 2 mg.2 The Ozempic coupon guide explains why Novo's savings offer needs a labeled use.
If you take it for type 2 diabetes
Here the alternatives are the drugs on the same diabetes label, and coverage usually decides more than the cash price.
- The Ozempic pill. Semaglutide as a daily tablet. The label covers the same use as the pen: "as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus."9 It is not a mg-for-mg swap with Rybelsus, the older semaglutide tablet: the label says the two "are not substitutable on a mg-to-mg basis".9 NovoCare Pharmacy sells it with "self-pay options starting at $149/month" for people who are uninsured or whose commercial plan does not cover it.10 A self-pay fill is processed outside your insurance and does not count toward a deductible.10 The Rybelsus guide covers the move from Rybelsus to the Ozempic pill.
- Mounjaro. Lilly's tirzepatide on a diabetes label, indicated "to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus."5 SURPASS-2 put it against Ozempic's 1 mg dose for 40 weeks in 1,879 adults: A1C fell 2.01 to 2.30 points on the three tirzepatide doses against 1.86 on semaglutide, and weight fell 1.9 to 5.5 kg more on tirzepatide. Lilly funded the trial.6 The Mounjaro cost guide prices it.
- Compounded semaglutide. The board above sells to anyone with a prescription, diabetes or not, with the same FDA caveat as before.1 If your plan already covers a diabetes drug, check your copay against the board before you switch to paying cash.
| Ozempic alternative | Molecule | Label | Form | Paying cash |
|---|---|---|---|---|
| Ozempic pill | semaglutide | Type 2 diabetes | daily tablet | Novo's price: from $149 a month |
| Mounjaro | tirzepatide | Type 2 diabetes | weekly injection | Lilly's price, in the Mounjaro cost guide |
| Wegovy | semaglutide | Weight loss | weekly injection or daily tablet | Novo's prices above |
| Zepbound | tirzepatide | Weight loss | weekly injection | Lilly's ladder above |
| Compounded semaglutide | semaglutide | None, not FDA-approved | weekly injection | live on the board above |
Changing from one diabetes medicine to another is your prescriber's decision, including the starting dose; none of these is a straight swap.
All six side by side
| Alternative | Molecule | FDA-approved for weight loss | Form | What it costs |
|---|---|---|---|---|
| Compounded semaglutide | semaglutide | No, not FDA-approved | weekly injection | live on the board above |
| Wegovy, NovoCare | semaglutide | Yes | weekly injection | Novo's prices: $199 for two months for new patients, then $349 |
| Wegovy pill | semaglutide | Yes | daily tablet | Novo's prices: $149 to $299 by dose |
| Foundayo | orforglipron | Yes | daily tablet | Lilly's price: from $149 at the lowest dose |
| Zepbound, Lilly self-pay | tirzepatide | Yes | weekly injection | Lilly's self-pay ladder above, by dose |
| Compounded tirzepatide | tirzepatide | No, not FDA-approved | weekly injection | live on the board above |
Ozempic and Mounjaro are left out of this table because neither is approved for weight loss; their alternatives are in the Ozempic section above.
Which one fits
- You want the lowest monthly price and accept a compounded product: compounded semaglutide keeps you on the molecule you already know.
- You want to stay on approved Wegovy for less: NovoCare self-pay, or the Wegovy pill, which costs less than the pen at every dose.
- You want the best trial result: tirzepatide, as Zepbound from Lilly self-pay or compounded from the board.
- You do not want injections: the Wegovy pill or Foundayo, both priced lowest at their starting doses.
- You have type 2 diabetes: ask whether your plan covers Ozempic, the Ozempic pill or Mounjaro before paying cash for anything.
Switching between any of these is a prescribing decision with its own dose plan; follow your prescriber.








